EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.629
https://www.valueinhealthjournal.com/article/S1098-3015(23)03759-2/fulltext
Section Title :
Section Order : 10123
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03759-2&doi=10.1016/j.jval.2023.09.629
HEOR Topics :
Tags :
Regions :